Safety and Outcome of Pharmacy-Led Vancomycin Dosing and Monitoring

Publisher： Karger

E-ISSN： 1421-9794|61|1|3-7

ISSN： 0009-3157

Source： Chemotherapy, Vol.61, Iss.1, 2015-0, pp. : 3-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concurrent Frusemide‐Theophylline Dosing Reduces Serum Vancomycin Concentrations in Preterm Infants

By  

The Australian Journal of Hospital Pharmacy, Vol. 29, Iss. 5, 1999-10 ,pp. : 269-272

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacy Simulation: A Scottish, Student-Led Perspective with Lessons for the UK and Beyond

By Regan Kirsty   Harney Lisa   Goodhand Kate   Strath Alison   Vosper Helen  

Pharmacy, Vol. 2, Iss. 1, 2014-02 ,pp. : 50-64

MDPI

Access to resources Recommend Favorite

Safety Monitoring in Clinical Trials

By Yao Bin   Zhu Li   Jiang Qi   Xia H. Amy  

Pharmaceutics, Vol. 5, Iss. 1, 2013-01 ,pp. : 94-106

MDPI

Access to resources Recommend Favorite

Clinical Efficacy and Safety of the Combination of Colistin plus Vancomycin for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-12 ,pp. : 225-231

Karger

Access to resources Recommend Favorite

Is Peak Concentration Needed in Therapeutic Drug Monitoring of Vancomycin? A Pharmacokinetic-Pharmacodynamic Analysis in Patients with Methicillin-Resistant Staphylococcus aureus Pneumonia

By  

Chemotherapy, Vol. 58, Iss. 4, 2012-11 ,pp. : 308-312

Karger

Access to resources Recommend Favorite